TRENDS IN BIOCHEMICAL SCIENCES is a premier academic journal published by CELL PRESS, focusing on the latest advancements and insights in the dynamic fields of biochemistry and molecular biology. With an ISSN of 0968-0004 and an E-ISSN of 1362-4326, this journal has established itself as a leading source of high-impact research, boasting an impressive Q1 category ranking in both Biochemistry and Molecular Biology as of 2023. The journal's Scopus Ranks further highlight its significance, placing it in the top 3% and 4% of its respective fields, emphasizing its role as a vital platform for disseminating innovative research. Published since 1976 and continuing through 2024, TRENDS IN BIOCHEMICAL SCIENCES provides a comprehensive overview of the latest trends, methods, and applications, helping researchers, professionals, and students stay at the forefront of their disciplines. Although it offers traditional access options, the journal's rich content and authoritative analysis make it a must-read for those pursuing cutting-edge biochemical research.

Cell Reports Methods is a cutting-edge journal published by CELL PRESS, focusing on innovative methodologies in the vast fields of biochemistry, genetics, biotechnology, and radiological sciences. Launched in 2021, it has rapidly ascended to attain a Q1 ranking across multiple disciplines in the latest 2023 metrics, reflecting its influential contribution to the scientific community. With an emphasis on practical and rigorous experimental approaches, this journal serves as a vital resource for researchers looking to advance their methodologies and collaborate on significant findings in their respective specialties. Despite not being an open-access publication, Cell Reports Methods ensures broad accessibility through institutional subscriptions, allowing researchers from various backgrounds to engage with high-quality scholarly work. The journal presents a unique platform for sharing insights from interdisciplinary methods that foster innovation and discovery, ultimately shaping the future of scientific research.

JOURNAL OF BIOLOGICAL CHEMISTRY, published by Elsevier, is a premier interdisciplinary journal dedicated to advancing our understanding of biochemistry, cell biology, and molecular biology. With a prestigious history dating back to 1945 and an impressive convergence of research expected to continue through 2024, this journal holds a Q1 ranking in all three of its core categories, signaling its critical influence in the respective fields, supported by a robust Scopus ranking that places it among the top echelons of internationally recognized research. Although currently not available as Open Access, the journal is essential for researchers and professionals looking to stay abreast of the latest breakthroughs and innovations in biochemical research. With a deep commitment to scientific rigor and a focus on diverse topics ranging from cellular processes to molecular mechanisms, the Journal of Biological Chemistry serves as a vital resource for the academic community, shaping the future of biological sciences.

INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, published by Wiley, is a leading peer-reviewed journal dedicated to the field of experimental pathology. With an ISSN of 0959-9673 and E-ISSN 1365-2613, the journal has been a vital resource for researchers and professionals since its inception in 1990, covering a broad spectrum of topics within pathology, cell biology, and molecular biology. The journal's relevancy is underscored by its Q2 ranking in Pathology and Forensic Medicine and Q3 rankings in both Cell Biology and Molecular Biology, as of 2023, reflecting its significant contribution to the scientific community. Although it does not currently offer open access options, readers can benefit from its insightful research articles and reviews that guide advancements in diagnostic pathology and therapeutic strategies. As the journal continues to evolve, it remains committed to facilitating the exchange of innovative ideas and findings that drive progress in experimental pathology and related fields, making it an indispensable platform for scientists, clinicians, and students alike.

FEBS LETTERS, published by Wiley, is a prestigious journal that has firmly established its place in the fields of biochemistry, biophysics, genetics, molecular biology, cell biology, and structural biology. With an esteemed history dating back to 1968, this journal continues to be a vital resource for researchers and professionals involved in the biological sciences. It boasts impressive quartile rankings, including Q1 statuses in several categories such as Biochemistry and Genetics, reflecting its high impact factor and significant contribution to scientific discourse. FEBS LETTERS provides a platform for innovative findings and critical reviews, fostering the exchange of knowledge and ideas within the scientific community. Although it operates under a subscription model, the journal ensures broad dissemination of groundbreaking research through its rigorous peer-review process. The vibrant discussions encouraged by articles published in FEBS LETTERS aim to inspire current and future generations of scientists to push the boundaries of biological understanding, making it an indispensable resource for anyone dedicated to advancing their knowledge in these dynamic fields.

Medical Molecular Morphology, published by SPRINGER JAPAN KK, stands as a significant resource in the fields of medicine and molecular biology, bridging critical insights between histological studies and modern therapeutic approaches. With an ISSN of 1860-1480 and E-ISSN of 1860-1499, this journal has evolved since its inception in 1996 and has continued to provide a platform for innovative research through 2024, establishing its relevance particularly in the realms of medical pathology and molecular morphology. Although categorized as Q3 in Medicine (miscellaneous) and Q4 in Molecular Biology per the 2023 quartiles, the journal's unique contributions cannot be understated, as evidenced by its Scopus rankings, which place it in the 52nd percentile for Pathology and 19th percentile for Molecular Biology. The journal’s mission focuses on disseminating valuable findings that enhance the understanding of cellular and molecular structures and their implications in health and disease. As access options are not currently open access, it remains essential for professionals and researchers to consider the journal's contributions as they pursue academic growth and impactful research in these dynamic fields.

HISTOCHEMISTRY AND CELL BIOLOGY, published by SPRINGER, is a prominent journal dedicated to advancing the fields of histochemistry and cell biology. With an ISSN of 0948-6143 and an E-ISSN of 1432-119X, this journal has carved a significant niche since its inception in 1995, striving for excellence in research dissemination through a rigorous peer-review process. The journal's impact is reflected in its strong performance across various academic categories, achieving a Q1 ranking in Medical Laboratory Technology, Q2 in Histology, and maintaining a credible presence in Cell and Molecular Biology. Nestled in Germany, and with the backing of a reputable publisher, HISTOCHEMISTRY AND CELL BIOLOGY serves as a pivotal platform for researchers, professionals, and students, fostering innovations that push the boundaries of our understanding of cellular processes. While the journal is not open access, it offers subscription-based access options ensuring comprehensive coverage of crucial findings in the rapidly evolving arena of cell biology and histochemistry.

Physiological Reports is a pioneering open-access journal published by WILEY, dedicated to advancing the field of physiology through the dissemination of high-quality research. Since its inception in 2013, this journal has provided a platform for innovative studies in both general physiology and medical physiology, making significant contributions to our understanding of biological processes. With an impact factor that reflects its growing influence—as evidenced by its placement in the Q2 category for physiology and medical physiology in 2023—Physiological Reports is positioned as a vital resource for researchers and practitioners alike. The journal encourages the submission of diverse studies ranging from cellular mechanisms to systemic physiology, presenting a unique opportunity for authors to reach a global audience without access barriers. It has established a reputation for rigorous peer review and timely publication, ensuring that cutting-edge research is readily available to stimulate further inquiry and collaboration in the scientific community.

Annual Review of Biochemistry is a premier publication in the field of biochemistry, renowned for its comprehensive and critical reviews that collate significant advancements and insights since its inception in 1946. Published by Annual Reviews in the United States, this journal maintains a prestigious position within the academic community, boasting a Q1 ranking in the biochemistry category for 2023, with an impressive Scopus rank of #4 out of 438, placing it in the top 1% of its field. With a commitment to excellence, it serves as an essential resource for researchers, professionals, and students striving to stay at the forefront of biochemical research. While the journal does not operate on an open-access model, it continues to provide key insights and knowledge that fuel innovation and discovery in the life sciences. As it converges research from various eras up to 2024, Annual Review of Biochemistry remains a vital contributor to the development of molecular biology and genetics, catering to the needs of a diverse readership keen on advancing their understanding and expertise in biochemistry.

Organogenesis is a leading journal published by Taylor & Francis Inc, dedicated to advancing the field of developmental biology and regenerative medicine. With an ISSN of 1547-6278 and E-ISSN 1555-8592, this journal spans an extensive research scope that includes embryology, transplantation, and biomedical engineering, distinguishing itself as a crucial platform for researchers and practitioners alike. Its impact is reflected in its performance across various categories in 2023, earning Q3 rankings in Biomedical Engineering and Embryology, Q4 in Developmental Biology, and Q2 in Transplantation, showcasing its reputable standing among peer journals. Moreover, with Scopus rankings indicating strong positioning in the fields of medicine and biochemistry, Organogenesis is essential for those looking to publish or stay updated on pioneering research. The journal facilitates rigorous peer-review and offers a forum for disseminating innovative findings, making it an invaluable resource for academics, professionals, and students committed to understanding the complexities of organism development.